![John Green MD MBBCh PGCertMedEd FAoME FRCP](https://profiles-cardiff.imgix.net/attachments/10014?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Dr John Green
(e/fe)
MD MBBCh PGCertMedEd FAoME FRCP
Timau a rolau for John Green
Darllenydd Clinigol a Gastroenterolegydd Ymgynghorol
Trosolwyg
Rwy'n Ddarllenydd Clinigol yn y Ganolfan Addysg Feddygol, Ysgol Feddygaeth, ac yn Gastroenterolegydd Ymgynghorol ym Mwrdd Iechyd Prifysgol Caerdydd a'r Fro. Rwy'n Arweinydd Rhaglen ar gyfer Cyrsiau Israddedig a Addysgir yn yr Ysgol Feddygaeth, gan gynnwys Meddygaeth (MBBCh). Rwy'n darparu arweinyddiaeth strategol a gweithredol ar gyfer ein rhaglenni israddedig, gan weithio gyda chydweithwyr gwasanaethau academaidd a phroffesiynol i ddarparu profiad addysgol o ansawdd uchel, sicr o ansawdd i fyfyrwyr. Rwy'n falch iawn o fod yn 'Cardiff Med', ar ôl hyfforddi yma fy hun.
Rwy'n parhau i fwynhau fy ngwaith clinigol fel endosgopigydd. Trwy gydol fy ngyrfa, rwyf wedi dal sawl rôl arweinyddiaeth uwch mewn Gastroenteroleg yn fy ysbyty, Bwrdd Iechyd ac ar lefel genedlaethol. Rwyf wedi cyhoeddi mwy nag 80 o erthyglau mewn cyfnodolion a adolygir gan gymheiriaid, wedi ysgrifennu gwerslyfr ar gyfer myfyrwyr meddygol israddedig, wedi cyfrannu at ganllawiau ac wedi goruchwylio llawer o brosiectau.
Cyhoeddiad
2026
- Mohamed, S. A. et al., 2026. British Society of Gastroenterology and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland guidance on best practice for upper gastrointestinal endoscopy. Frontline Gastroenterology (10.1136/flgastro-2025-103455)
- Siau, K. et al., 2026. Career intentions of the UK endoscopy workforce: results from the 2023 UK-wide pan-workforce survey. Frontline Gastroenterology 17 , pp.45-57. (10.1136/flgastro-2024-103039)
2025
- Staffurth, J. N. et al. 2025. The impact of specialised gastroenterology services for pelvic radiation disease (PRD): Results from the prospective multi-centre EAGLE study. PLoS ONE 20 (1) e0303356. (10.1371/journal.pone.0303356)
2023
- Ur Rahman, A. et al., 2023. Unique case of abdominal aortic aneurysm causing obstructive jaundice and duodenal obstruction. Journal of the Royal College of Physicians of Edinburgh 53 (1), pp.30-34. (10.1177/14782715231152729)
- Wildman, A. et al., 2023. Do medical students value continuity of educational supervision?. Presented at: INHWE 3rd International Congress of Health Education and Research & AoME Annual Academic Meeting Cardiff 27-29 June 2023.
2021
- Ravindran, S. et al., 2021. National census of UK endoscopy services in 2019. Frontline Gastroenterology 12 , pp.451-460. (10.1136/flgastro-2020-101538)
- Haboubi, H. N. et al., 2021. Colonoscopic appearances of an appendiceal remnant: the benign masquerading as the sinister [Case report]. ACG Case Reports Journal 8 (8) e00655. (10.14309/crj.0000000000000655)
2020
- Desai, A. et al. 2020. 'Can you watch me please?' An evaluation of supervised learning events for medical students. The British Student Doctor Journal 4 (3), pp.16-18. (10.18573/bsdj.211)
- Ray, I. et al. 2020. The role of educational supervisors and their feedback in an undergraduate medical curriculum. The British Student Doctor Journal 4 (3), pp.31-33. (10.18573/bsdj.200)
- Ludlow, H. et al., 2020. Gastrointestinal symptoms of pelvic radiation disease (part 4): professional awareness and specialist support. Gastrointestinal Nursing 18 (5), pp.30-34. (10.12968/gasn.2020.18.5.30)
- Farnell, D. et al. 2020. The ALERT-B questionnaire: a screening tool for the detection of gastroenterological late effects after radiotherapy for prostate cancer. Clinical and Translational Radiation Oncology 21 , pp.98-103. (10.1016/j.ctro.2020.02.002)
- Ludlow, H. and Green, J. 2020. Gastrointestinal symptoms of pelvic radiation disease (part 1): literature review. Gastrointestinal Nursing 18 (2), pp.40-45. (10.12968/gasn.2020.18.2.40)
2019
- Green, J. et al. 2019. JAG accreditation programme. Meeting the quality and safety standards guidance. Project Report.London: Royal College of Physicians.
- Edwards, P. J. , Stechman, M. J. and Green, J. T. 2019. How to pass the emergency OSCE station. British Medical Journal 367 l2414. (10.1136/sbmj.l2414)
- Narula, P. et al., 2019. Paediatric endoscopy global rating scale. Journal of Pediatric Gastroenterology and Nutrition 69 (2), pp.171-175. (10.1097/MPG.0000000000002355)
- Di Caro, S. et al., 2019. Multicentre randomised controlled trial comparing standard and high resolution optical technologies in colorectal cancer screening. Frontline Gastroenterology 10 , pp.244-252. (10.1136/flgastro-2018-101130)
- Siau, K. et al., 2019. Impact of the Joint Advisory Group on Gastrointestinal Endoscopy (JAG) on endoscopy services in the UK and beyond. Frontline Gastroenterology 10 , pp.93-106. (10.1136/flgastro-2018-100969)
- Shenbagaraj, L. et al., 2019. Endoscopy in 2017: a national survey of practice in the UK. Frontline Gastroenterology 10 , pp.7-15. (10.1136/flgastro-2018-100970)
2018
- Lawrie, T. A. et al., 2018. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers. Cochrane Library 1 (10.1002/14651858.CD012529.pub2)
2017
- Evans, D. , Owen, S. and Green, J. 2017. Role of a medical student: patient perspectives. Clinical Teacher 14 (4), pp.284-288. (10.1111/tct.12570)
- Shakespeare, R. , Green, J. and Turner, J. 2017. Eureka: Gastrointestinal medicine. Scion Publishing Ltd.
- Ludlow, H. , Green, J. and Turner, J. 2017. Late gastrointestinal effects of pelvic radiation: a nurse-led service. British Journal of Nursing 26 (4), pp.S15-S22. (10.12968/bjon.2017.26.4.S15)
- Lawrie, T. A. et al., 2017. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy. Cochrane Database of Systematic Reviews (10.1002/14651858.CD012529)
2016
- Taylor, S. et al. 2016. The three-item ALERT-B questionnaire provides a validated screening tool to detect chronic gastrointestinal symptoms after pelvic radiotherapy in cancer survivors. Clinical Oncology 28 (10), pp.e139-e147. (10.1016/j.clon.2016.06.004)
- Taylor, S. et al. 2016. Improving the well-being of men by Evaluating and Addressing the Gastrointestinal Late Effects (EAGLE) of radical treatment for prostate cancer: study protocol for a mixed-method implementation project. British Medical Journal Open 6 (10) e011773. (10.1136/bmjopen-2016-011773)
- Sugamaran, A. , Hurley, J. and Green, J. 2016. The liver. In: Fillit, H. M. , Rockwood, K. and Young, J. B. eds. Brocklehurst's Textbook of Geriatric Medicine and Gerontology. Elsevier. , pp.596-605.
- Freeman, P. et al. 2016. Chronic anemia and non-ST elevation acute coronary syndrome -double jeopardy. Current Medical Research and Opinion 32 (9), pp.1503-1509. (10.1080/03007995.2016.1182902)
2015
- Stacey, R. et al., 2015. PTU-324 Pelvic radiation disease – when do patients present to gastroenterology services? [Abstract]. Gut 64 (S1), pp.A204-A204. (10.1136/gutjnl-2015-309861.438)
2014
- Berrill, J. W. et al., 2014. Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels. Journal of Crohn's and Colitis 8 (9), pp.945-955. (10.1016/j.crohns.2014.01.018)
- Stacey, R. and Green, J. T. 2014. Radiation-induced small bowel disease: latest developments and clinical guidance. Therapeutic Advances in Chronic Disease 5 , pp.15-29. (10.1177/2040622313510730)
- Wilcox, C. , Turner, J. and Green, J. 2014. Systematic review: the management of chronic diarrhoea due to bile acid malabsorption. Alimentary Pharmacology and Therapeutics 39 (9), pp.923-939. (10.1111/apt.12684)
2013
- Berrill, J. W. et al., 2013. Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity. Alimentary Pharmacology and Therapeutics 38 (1), pp.44-51. (10.1111/apt.12335)
- Stacey, R. and Green, J. T. 2013. Nonendoscopic therapies for the management of radiation-induced rectal bleeding. Current Opinion in Supportive and Palliative Care 7 (2), pp.175-182. (10.1097/spc.0b013e32835f3e00)
- Keshk, K. , Green, J. T. and Swift, G. 2013. PWE-031 How many colorectal cancers (CRC) have been missed in the 36 months after ‘normal’ lower Gi endoscopy (colonoscopy/flexible sigmoidscopy) [Abstract]. Gut 62 , pp.A143-A143. (10.1136/gutjnl-2013-304907.320)
- Keshk, K. et al., 2013. A case of terminal ileal prolapse presenting as a polyp. Endoscopy 45 (S 02), pp.E159-E160. (10.1055/s-0032-1326496)
- Berrill, J. W. et al., 2013. An observational study of cognitive function in patients with irritable bowel syndrome and inflammatory bowel disease. Neurogastroenterology and Motility 25 (11), pp.918-e704. (10.1111/nmo.12219)
2012
- Berrill, J. W. et al., 2012. Upper gastrointestinal cancer in its early stages is predominantly asymptomatic. Frontline Gastroenterology 3 , pp.47-51. (10.1136/flgastro-2011-100026)
2011
- Lee, B. L. et al., 2011. Two for the price of one: a dual treatment benefit of long-acting octreotide in occult bleeding and diuretic intractable ascites. Frontline Gastroenterology 2 (4), pp.226-229. (10.1136/fg.2010.003459)
- Eadala, P. et al. 2011. Association of lactose sensitivity with inflammatory bowel disease - demonstrated by analysis of genetic polymorphism, breath gases and symptoms. Alimentary Pharmacology & Therapeutics 34 (7), pp.735-746. (10.1111/j.1365-2036.2011.04799.x)
- Skitt, L. C. et al., 2011. Helping the general physician to improve outcomes after PEG insertion: how we changed our practice. Clinical Medicine 11 (2), pp.132-137. (10.7861/clinmedicine.11-2-132)
2010
- Campbell, A. K. et al. 2010. Bacterial metabolic 'toxins': A new mechanism for lactose and food intolerance, and irritable bowel syndrome. Toxicology 278 (3), pp.268-276. (10.1016/j.tox.2010.09.001)
- Hurley, J. J. et al., 2010. Surveillance for colorectal cancer in patients with inflammatory bowel disease. British Journal of Hospital Medicine 71 (10), pp.562-567. (10.12968/hmed.2010.71.10.78939)
- Turner, J. , Green, J. and Dolwani, S. 2010. Use of gelofusine for endoscopic mucosal resection [Letter]. Gut 59 , pp.1446-1447. (10.1136/gut.2009.198648)
- Turner, J. et al., 2010. Percutaneous endoscopic gastrostomy tube replacement. Endoscopy 42 , pp.E146-E147. (10.1055/s-0029-1244102)
- Eadala, P. et al. 2010. Lactose in drugs: avoided or allowed to lactose maldigesters? Authors' reply. Alimentary Pharmacology & Therapeutics 31 (8), pp.925-926. (10.1111/j.1365-2036.2010.04253.x)
2009
- Eadala, P. et al. 2009. Lactose content of gastrointestinal drugs; does it matter? Authors' reply [Letter]. Alimentary Pharmacology & Therapeutics 29 (11), pp.1213. (10.1111/j.1365-2036.2009.04006.x)
- Eadala, P. et al. 2009. Quantifying the 'hidden' lactose in drugs used for the treatment of gastrointestinal conditions. Alimentary Pharmacology & Therapeutics 29 (6), pp.677-687. (10.1111/j.1365-2036.2008.03889.x)
2008
- Turner, J. et al., 2008. Stents and stentability: treatment for malignant bowel obstruction. British Journal of Hospital Medicine 69 (12), pp.676-680. (10.12968/hmed.2008.69.12.676)
- Turner, J. and Green, J. 2008. Hepatitis E: a UK perspective. British Journal of Hospital Medicine 69 (9), pp.517-519. (10.12968/hmed.2008.69.9.31047)
- Turner, J. K. and Green, J. T. 2008. Iron deficiency anaemia guidelines: time for an update? [Letter]. Gut 57 (9), pp.1330-1331.
- Eadala, P. et al. 2008. Lactose intolerance and inflammatory bowel disease [Abstract]. Gut 57 (S1), pp.A115-A115.
2007
- Dinani, N. , Ludlow, H. and Green, J. T. 2007. Development of a referral pathway for psychological support in IBD. Gastrointestinal Nursing 5 (9), pp.24-31. (10.12968/gasn.2007.5.9.27565)
- Eadala, P. et al. 2007. "Hidden" lactose in drugs may contribute to symptoms in patients with gastrointestinal conditions and coexisting lactose sensitivity [Abstract]. Gut 56 (S2), pp.A142.
2006
- Hudson, B. and Green, J. 2006. British Society of Gastroenterology guidelines for ulcerative colitis surveillance: creating consensus or confusion? [Letter]. Gut 55 , pp.1052-1053. (10.1136/gut.2006.092643)
- Sundar, N. et al., 2006. Does endoscopy diagnose early gastrointestinal cancer in patients with uncomplicated dyspepsia?. Postgraduate Medical Journal 82 (963), pp.52-54. (10.1136/pgmj.2005.034033)
2005
- Ingram, J. R. et al. 2005. A randomized trial of nicotine enemas for active ulcerative colitis. Clinical Gastroenterology and Hepatology 3 (11), pp.1107-1114. (10.1016/S1542-3565(05)00849-9)
2004
- Hussain, S. F. et al., 2004. Massive pleural effusion and marked increase of CA-125. Postgraduate Medical Journal 80 (943), pp.300-301. (10.1136/pgmj.2003.012377)
- McKirdy, H. C. et al., 2004. Differential effect of nitric oxide synthase inhibition on sigmoid colon longitudinal and circular muscle responses to nicotine and nerve stimulation in vitro. British Journal of Surgery 91 (2), pp.229-234. (10.1002/bjs.4395)
2003
- Sandborn, W. J. et al., 2003. Nicotine tartrate liquid enemas for mildly to moderately active left‐sided ulcerative colitis unresponsive to first‐line therapy: a pilot study. Alimentary Pharmacology and Therapeutics 11 (4), pp.663-671. (10.1046/j.1365-2036.1997.00208.x)
- Thomas, P. D. et al., 2003. Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut 52 (S5), pp.v1-v15. (10.1136/gut.52.suppl_5.v1)
- Richardson, C. et al., 2003. Effect of smoking and transdermal nicotine on colonic nicotinic acetylcholine receptors in ulcerative colitis. QJM: An International Journal of Medicine 96 (1), pp.57-65. (10.1093/qjmed/hcg007)
2001
- Hawkes, N. D. et al., 2001. Enteric‐release glyceryl trinitrate in active Crohn’s disease: a randomized, double‐blind, placebo‐controlled trial. Alimentary Pharmacology and Therapeutics 15 (12), pp.1867-1873. (10.1046/j.1365-2036.2001.01120.x)
- Richardson, C. E. et al., 2001. Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the α3 nicotinic acetylcholine receptor subunit. Gastroenterology 121 (2), pp.350-357. (10.1053/gast.2001.26320)
- Green, J. et al. 2001. Reply—nicotine‐induced NO release in colitis [Letter]. Alimentary Pharmacology and Therapeutics 15 (4), pp.561-561. (10.1046/j.1365-2036.2001.0877d.x)
2000
- Green, J. T. et al. 2000. Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis. Alimentary Pharmacology and Therapeutics 14 (11), pp.1429-1434. (10.1046/j.1365-2036.2000.00847.x)
- Thomas, G. A. O. et al., 2000. Role of smoking in inflammatory bowel disease: implications for therapy. Postgraduate Medical Journal 76 (895), pp.273-279. (10.1136/pmj.76.895.273)
1999
- Green, J. T. et al. 1999. An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics. British Journal of Clinical Pharmacology 48 (4), pp.485-493. (10.1046/j.1365-2125.1999.00057.x)
1998
- Green, J. T. et al. 1998. Clinical status of ulcerative colitis in patients who smoke. The American Journal of Gastroenterology 93 (9), pp.1463-1467. (10.1111/j.1572-0241.1998.00464.x)
- Rhodes, J. , Green, J. and Thomas, G. 1998. Nicotine and the gastrointestinal tract. In: Benowitz, N. L. ed. Nicotine Safety and Toxicity. Oxford University Press. , pp.161-166. (10.1093/oso/9780195114966.003.0015)
- Green, J. et al. 1998. Nicotine carbomer enemas - pharmacokinetics of a revised formulation. Italian Journal of Gastroenterology and Hepatology 30 (3), pp.260-265.
- Kapur, K. C. et al., 1998. Auditing mortality from upper gastrointestinal haemorrhage: impact of a high dependency unit. Journal of the Royal College of Physicians of London 32 (3), pp.246-250. (10.1016/S0035-8819(25)00017-0)
- Thomas, G. A. O. et al., 1998. Controlled trial of antituberculous chemotherapy in Crohn’s disease: a five year follow up study. Gut 42 (4), pp.497-500. (10.1136/gut.42.4.497)
- Thomas, G. , Rhodes, J. and Green, J. T. 1998. Inflammatory bowel disease and smoking—A review. The American Journal of Gastroenterology 93 (2), pp.144-149. (10.1016/S0002-9270(97)00083-X)
- Rhodes, J. and Green, J. T. 1998. Alternative concepts for the aetiology and pathogenesis of inflammatory bowel disease. In: Campieri, M. et al., Clinical Challenges in Inflammatory Bowel Diseases: Diagnosis, Prognosis and Treatment: 97 (Falk Symposium, 97). Kluwer Academic Publishers. , pp.25-28.
1997
- Green, J. T. et al. 1997. Nicotine enemas for active ulcerative colitis—a pilot study. Alimentary Pharmacology and Therapeutics 11 (5), pp.859-863. (10.1046/j.1365-2036.1997.00220.x)
- Green, J. T. et al. 1997. Pharmacokinetics of nicotine carbomer enemas: A new treatment modality for ulcerative colitis. Clinical Pharmacology & Therapeutics 61 (3), pp.340-348. (10.1016/S0009-9236(97)90167-3)
- Green, J. T. , Thomas, G. A. O. and Rhodes, J. 1997. Nicotine: therapeutic potential for the treatment of ulcerative colitis. Expert Opinion on Investigational Drugs 6 (1), pp.17-22. (10.1517/13543784.6.1.17)
- Davies, J. S. et al., 1997. Growth hormone use by body builders [Letter]. British Journal of Sports Medicine 31 (4), pp.352-353. (10.1136/bjsm.31.4.352-b)
- Green, J. et al. 1997. Koch's or Crohn's - or something else? [Letter]. International Journal of Clinical Practice 51 (7), pp.480-480. (10.1111/j.1742-1241.1997.tb11525.x)
1996
- Thomas, G. A. O. , Rhodes, J. and Green, J. 1996. Nicotine and gastrointestinal disease [Editorial]. QJM: An International Journal of Medicine 89 (7), pp.485-488. (10.1093/qjmed/89.7.485)
- Rhodes, J. , Thomas, G. and Green, J. 1996. New developments in the treatment of inflammatory bowel disease. Romanian Journal of Gastroenterology 5 , pp.97-100.
- Rhodes, J. , Thomas, G. A. O. and Green, J. T. 1996. Nicotine for the treatment of ulcerative colitis. Trends in Inflammatory Bowel Disease Therapy 24 , pp.217-220.
- Rhodes, J. , Thomas, G. A. and Green, J. T. 1996. Nicotine for the treatment of ulcerative colitis. In: Opitz, K. ed. Nicotine as a Therapeutic Agent. Symposium der Stiftung Immunitat und Umwelt May 15 1996. Immunity and Environment Gustav Fischer. , pp.12-14.
1995
- David, H. G. et al., 1995. Simultaneous bilateral quadriceps rupture: a complication of anabolic steroid abuse [Letter]. Journal of Bone and Joint Surgery, British Volume 77-B (1), pp.159-160. (10.1302/0301-620X.77B1.7822381)
1994
- Singh, G. , Wijesurendra, C. S. and Green, J. T. 1994. Disseminated aspergillosis in the acquired immunodeficiency syndrome. International Journal of STD & AIDS 5 (1), pp.63-66. (10.1177/095646249400500116)
Articles
- Mohamed, S. A. et al., 2026. British Society of Gastroenterology and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland guidance on best practice for upper gastrointestinal endoscopy. Frontline Gastroenterology (10.1136/flgastro-2025-103455)
- Siau, K. et al., 2026. Career intentions of the UK endoscopy workforce: results from the 2023 UK-wide pan-workforce survey. Frontline Gastroenterology 17 , pp.45-57. (10.1136/flgastro-2024-103039)
- Staffurth, J. N. et al. 2025. The impact of specialised gastroenterology services for pelvic radiation disease (PRD): Results from the prospective multi-centre EAGLE study. PLoS ONE 20 (1) e0303356. (10.1371/journal.pone.0303356)
- Ur Rahman, A. et al., 2023. Unique case of abdominal aortic aneurysm causing obstructive jaundice and duodenal obstruction. Journal of the Royal College of Physicians of Edinburgh 53 (1), pp.30-34. (10.1177/14782715231152729)
- Ravindran, S. et al., 2021. National census of UK endoscopy services in 2019. Frontline Gastroenterology 12 , pp.451-460. (10.1136/flgastro-2020-101538)
- Haboubi, H. N. et al., 2021. Colonoscopic appearances of an appendiceal remnant: the benign masquerading as the sinister [Case report]. ACG Case Reports Journal 8 (8) e00655. (10.14309/crj.0000000000000655)
- Desai, A. et al. 2020. 'Can you watch me please?' An evaluation of supervised learning events for medical students. The British Student Doctor Journal 4 (3), pp.16-18. (10.18573/bsdj.211)
- Ray, I. et al. 2020. The role of educational supervisors and their feedback in an undergraduate medical curriculum. The British Student Doctor Journal 4 (3), pp.31-33. (10.18573/bsdj.200)
- Ludlow, H. et al., 2020. Gastrointestinal symptoms of pelvic radiation disease (part 4): professional awareness and specialist support. Gastrointestinal Nursing 18 (5), pp.30-34. (10.12968/gasn.2020.18.5.30)
- Farnell, D. et al. 2020. The ALERT-B questionnaire: a screening tool for the detection of gastroenterological late effects after radiotherapy for prostate cancer. Clinical and Translational Radiation Oncology 21 , pp.98-103. (10.1016/j.ctro.2020.02.002)
- Ludlow, H. and Green, J. 2020. Gastrointestinal symptoms of pelvic radiation disease (part 1): literature review. Gastrointestinal Nursing 18 (2), pp.40-45. (10.12968/gasn.2020.18.2.40)
- Edwards, P. J. , Stechman, M. J. and Green, J. T. 2019. How to pass the emergency OSCE station. British Medical Journal 367 l2414. (10.1136/sbmj.l2414)
- Narula, P. et al., 2019. Paediatric endoscopy global rating scale. Journal of Pediatric Gastroenterology and Nutrition 69 (2), pp.171-175. (10.1097/MPG.0000000000002355)
- Di Caro, S. et al., 2019. Multicentre randomised controlled trial comparing standard and high resolution optical technologies in colorectal cancer screening. Frontline Gastroenterology 10 , pp.244-252. (10.1136/flgastro-2018-101130)
- Siau, K. et al., 2019. Impact of the Joint Advisory Group on Gastrointestinal Endoscopy (JAG) on endoscopy services in the UK and beyond. Frontline Gastroenterology 10 , pp.93-106. (10.1136/flgastro-2018-100969)
- Shenbagaraj, L. et al., 2019. Endoscopy in 2017: a national survey of practice in the UK. Frontline Gastroenterology 10 , pp.7-15. (10.1136/flgastro-2018-100970)
- Lawrie, T. A. et al., 2018. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers. Cochrane Library 1 (10.1002/14651858.CD012529.pub2)
- Evans, D. , Owen, S. and Green, J. 2017. Role of a medical student: patient perspectives. Clinical Teacher 14 (4), pp.284-288. (10.1111/tct.12570)
- Ludlow, H. , Green, J. and Turner, J. 2017. Late gastrointestinal effects of pelvic radiation: a nurse-led service. British Journal of Nursing 26 (4), pp.S15-S22. (10.12968/bjon.2017.26.4.S15)
- Lawrie, T. A. et al., 2017. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy. Cochrane Database of Systematic Reviews (10.1002/14651858.CD012529)
- Taylor, S. et al. 2016. The three-item ALERT-B questionnaire provides a validated screening tool to detect chronic gastrointestinal symptoms after pelvic radiotherapy in cancer survivors. Clinical Oncology 28 (10), pp.e139-e147. (10.1016/j.clon.2016.06.004)
- Taylor, S. et al. 2016. Improving the well-being of men by Evaluating and Addressing the Gastrointestinal Late Effects (EAGLE) of radical treatment for prostate cancer: study protocol for a mixed-method implementation project. British Medical Journal Open 6 (10) e011773. (10.1136/bmjopen-2016-011773)
- Freeman, P. et al. 2016. Chronic anemia and non-ST elevation acute coronary syndrome -double jeopardy. Current Medical Research and Opinion 32 (9), pp.1503-1509. (10.1080/03007995.2016.1182902)
- Stacey, R. et al., 2015. PTU-324 Pelvic radiation disease – when do patients present to gastroenterology services? [Abstract]. Gut 64 (S1), pp.A204-A204. (10.1136/gutjnl-2015-309861.438)
- Berrill, J. W. et al., 2014. Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels. Journal of Crohn's and Colitis 8 (9), pp.945-955. (10.1016/j.crohns.2014.01.018)
- Stacey, R. and Green, J. T. 2014. Radiation-induced small bowel disease: latest developments and clinical guidance. Therapeutic Advances in Chronic Disease 5 , pp.15-29. (10.1177/2040622313510730)
- Wilcox, C. , Turner, J. and Green, J. 2014. Systematic review: the management of chronic diarrhoea due to bile acid malabsorption. Alimentary Pharmacology and Therapeutics 39 (9), pp.923-939. (10.1111/apt.12684)
- Berrill, J. W. et al., 2013. Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity. Alimentary Pharmacology and Therapeutics 38 (1), pp.44-51. (10.1111/apt.12335)
- Stacey, R. and Green, J. T. 2013. Nonendoscopic therapies for the management of radiation-induced rectal bleeding. Current Opinion in Supportive and Palliative Care 7 (2), pp.175-182. (10.1097/spc.0b013e32835f3e00)
- Keshk, K. , Green, J. T. and Swift, G. 2013. PWE-031 How many colorectal cancers (CRC) have been missed in the 36 months after ‘normal’ lower Gi endoscopy (colonoscopy/flexible sigmoidscopy) [Abstract]. Gut 62 , pp.A143-A143. (10.1136/gutjnl-2013-304907.320)
- Keshk, K. et al., 2013. A case of terminal ileal prolapse presenting as a polyp. Endoscopy 45 (S 02), pp.E159-E160. (10.1055/s-0032-1326496)
- Berrill, J. W. et al., 2013. An observational study of cognitive function in patients with irritable bowel syndrome and inflammatory bowel disease. Neurogastroenterology and Motility 25 (11), pp.918-e704. (10.1111/nmo.12219)
- Berrill, J. W. et al., 2012. Upper gastrointestinal cancer in its early stages is predominantly asymptomatic. Frontline Gastroenterology 3 , pp.47-51. (10.1136/flgastro-2011-100026)
- Lee, B. L. et al., 2011. Two for the price of one: a dual treatment benefit of long-acting octreotide in occult bleeding and diuretic intractable ascites. Frontline Gastroenterology 2 (4), pp.226-229. (10.1136/fg.2010.003459)
- Eadala, P. et al. 2011. Association of lactose sensitivity with inflammatory bowel disease - demonstrated by analysis of genetic polymorphism, breath gases and symptoms. Alimentary Pharmacology & Therapeutics 34 (7), pp.735-746. (10.1111/j.1365-2036.2011.04799.x)
- Skitt, L. C. et al., 2011. Helping the general physician to improve outcomes after PEG insertion: how we changed our practice. Clinical Medicine 11 (2), pp.132-137. (10.7861/clinmedicine.11-2-132)
- Campbell, A. K. et al. 2010. Bacterial metabolic 'toxins': A new mechanism for lactose and food intolerance, and irritable bowel syndrome. Toxicology 278 (3), pp.268-276. (10.1016/j.tox.2010.09.001)
- Hurley, J. J. et al., 2010. Surveillance for colorectal cancer in patients with inflammatory bowel disease. British Journal of Hospital Medicine 71 (10), pp.562-567. (10.12968/hmed.2010.71.10.78939)
- Turner, J. , Green, J. and Dolwani, S. 2010. Use of gelofusine for endoscopic mucosal resection [Letter]. Gut 59 , pp.1446-1447. (10.1136/gut.2009.198648)
- Turner, J. et al., 2010. Percutaneous endoscopic gastrostomy tube replacement. Endoscopy 42 , pp.E146-E147. (10.1055/s-0029-1244102)
- Eadala, P. et al. 2010. Lactose in drugs: avoided or allowed to lactose maldigesters? Authors' reply. Alimentary Pharmacology & Therapeutics 31 (8), pp.925-926. (10.1111/j.1365-2036.2010.04253.x)
- Eadala, P. et al. 2009. Lactose content of gastrointestinal drugs; does it matter? Authors' reply [Letter]. Alimentary Pharmacology & Therapeutics 29 (11), pp.1213. (10.1111/j.1365-2036.2009.04006.x)
- Eadala, P. et al. 2009. Quantifying the 'hidden' lactose in drugs used for the treatment of gastrointestinal conditions. Alimentary Pharmacology & Therapeutics 29 (6), pp.677-687. (10.1111/j.1365-2036.2008.03889.x)
- Turner, J. et al., 2008. Stents and stentability: treatment for malignant bowel obstruction. British Journal of Hospital Medicine 69 (12), pp.676-680. (10.12968/hmed.2008.69.12.676)
- Turner, J. and Green, J. 2008. Hepatitis E: a UK perspective. British Journal of Hospital Medicine 69 (9), pp.517-519. (10.12968/hmed.2008.69.9.31047)
- Turner, J. K. and Green, J. T. 2008. Iron deficiency anaemia guidelines: time for an update? [Letter]. Gut 57 (9), pp.1330-1331.
- Eadala, P. et al. 2008. Lactose intolerance and inflammatory bowel disease [Abstract]. Gut 57 (S1), pp.A115-A115.
- Dinani, N. , Ludlow, H. and Green, J. T. 2007. Development of a referral pathway for psychological support in IBD. Gastrointestinal Nursing 5 (9), pp.24-31. (10.12968/gasn.2007.5.9.27565)
- Eadala, P. et al. 2007. "Hidden" lactose in drugs may contribute to symptoms in patients with gastrointestinal conditions and coexisting lactose sensitivity [Abstract]. Gut 56 (S2), pp.A142.
- Hudson, B. and Green, J. 2006. British Society of Gastroenterology guidelines for ulcerative colitis surveillance: creating consensus or confusion? [Letter]. Gut 55 , pp.1052-1053. (10.1136/gut.2006.092643)
- Sundar, N. et al., 2006. Does endoscopy diagnose early gastrointestinal cancer in patients with uncomplicated dyspepsia?. Postgraduate Medical Journal 82 (963), pp.52-54. (10.1136/pgmj.2005.034033)
- Ingram, J. R. et al. 2005. A randomized trial of nicotine enemas for active ulcerative colitis. Clinical Gastroenterology and Hepatology 3 (11), pp.1107-1114. (10.1016/S1542-3565(05)00849-9)
- Hussain, S. F. et al., 2004. Massive pleural effusion and marked increase of CA-125. Postgraduate Medical Journal 80 (943), pp.300-301. (10.1136/pgmj.2003.012377)
- McKirdy, H. C. et al., 2004. Differential effect of nitric oxide synthase inhibition on sigmoid colon longitudinal and circular muscle responses to nicotine and nerve stimulation in vitro. British Journal of Surgery 91 (2), pp.229-234. (10.1002/bjs.4395)
- Sandborn, W. J. et al., 2003. Nicotine tartrate liquid enemas for mildly to moderately active left‐sided ulcerative colitis unresponsive to first‐line therapy: a pilot study. Alimentary Pharmacology and Therapeutics 11 (4), pp.663-671. (10.1046/j.1365-2036.1997.00208.x)
- Thomas, P. D. et al., 2003. Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut 52 (S5), pp.v1-v15. (10.1136/gut.52.suppl_5.v1)
- Richardson, C. et al., 2003. Effect of smoking and transdermal nicotine on colonic nicotinic acetylcholine receptors in ulcerative colitis. QJM: An International Journal of Medicine 96 (1), pp.57-65. (10.1093/qjmed/hcg007)
- Hawkes, N. D. et al., 2001. Enteric‐release glyceryl trinitrate in active Crohn’s disease: a randomized, double‐blind, placebo‐controlled trial. Alimentary Pharmacology and Therapeutics 15 (12), pp.1867-1873. (10.1046/j.1365-2036.2001.01120.x)
- Richardson, C. E. et al., 2001. Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the α3 nicotinic acetylcholine receptor subunit. Gastroenterology 121 (2), pp.350-357. (10.1053/gast.2001.26320)
- Green, J. et al. 2001. Reply—nicotine‐induced NO release in colitis [Letter]. Alimentary Pharmacology and Therapeutics 15 (4), pp.561-561. (10.1046/j.1365-2036.2001.0877d.x)
- Green, J. T. et al. 2000. Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis. Alimentary Pharmacology and Therapeutics 14 (11), pp.1429-1434. (10.1046/j.1365-2036.2000.00847.x)
- Thomas, G. A. O. et al., 2000. Role of smoking in inflammatory bowel disease: implications for therapy. Postgraduate Medical Journal 76 (895), pp.273-279. (10.1136/pmj.76.895.273)
- Green, J. T. et al. 1999. An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics. British Journal of Clinical Pharmacology 48 (4), pp.485-493. (10.1046/j.1365-2125.1999.00057.x)
- Green, J. T. et al. 1998. Clinical status of ulcerative colitis in patients who smoke. The American Journal of Gastroenterology 93 (9), pp.1463-1467. (10.1111/j.1572-0241.1998.00464.x)
- Green, J. et al. 1998. Nicotine carbomer enemas - pharmacokinetics of a revised formulation. Italian Journal of Gastroenterology and Hepatology 30 (3), pp.260-265.
- Kapur, K. C. et al., 1998. Auditing mortality from upper gastrointestinal haemorrhage: impact of a high dependency unit. Journal of the Royal College of Physicians of London 32 (3), pp.246-250. (10.1016/S0035-8819(25)00017-0)
- Thomas, G. A. O. et al., 1998. Controlled trial of antituberculous chemotherapy in Crohn’s disease: a five year follow up study. Gut 42 (4), pp.497-500. (10.1136/gut.42.4.497)
- Thomas, G. , Rhodes, J. and Green, J. T. 1998. Inflammatory bowel disease and smoking—A review. The American Journal of Gastroenterology 93 (2), pp.144-149. (10.1016/S0002-9270(97)00083-X)
- Green, J. T. et al. 1997. Nicotine enemas for active ulcerative colitis—a pilot study. Alimentary Pharmacology and Therapeutics 11 (5), pp.859-863. (10.1046/j.1365-2036.1997.00220.x)
- Green, J. T. et al. 1997. Pharmacokinetics of nicotine carbomer enemas: A new treatment modality for ulcerative colitis. Clinical Pharmacology & Therapeutics 61 (3), pp.340-348. (10.1016/S0009-9236(97)90167-3)
- Green, J. T. , Thomas, G. A. O. and Rhodes, J. 1997. Nicotine: therapeutic potential for the treatment of ulcerative colitis. Expert Opinion on Investigational Drugs 6 (1), pp.17-22. (10.1517/13543784.6.1.17)
- Davies, J. S. et al., 1997. Growth hormone use by body builders [Letter]. British Journal of Sports Medicine 31 (4), pp.352-353. (10.1136/bjsm.31.4.352-b)
- Green, J. et al. 1997. Koch's or Crohn's - or something else? [Letter]. International Journal of Clinical Practice 51 (7), pp.480-480. (10.1111/j.1742-1241.1997.tb11525.x)
- Thomas, G. A. O. , Rhodes, J. and Green, J. 1996. Nicotine and gastrointestinal disease [Editorial]. QJM: An International Journal of Medicine 89 (7), pp.485-488. (10.1093/qjmed/89.7.485)
- Rhodes, J. , Thomas, G. and Green, J. 1996. New developments in the treatment of inflammatory bowel disease. Romanian Journal of Gastroenterology 5 , pp.97-100.
- Rhodes, J. , Thomas, G. A. O. and Green, J. T. 1996. Nicotine for the treatment of ulcerative colitis. Trends in Inflammatory Bowel Disease Therapy 24 , pp.217-220.
- David, H. G. et al., 1995. Simultaneous bilateral quadriceps rupture: a complication of anabolic steroid abuse [Letter]. Journal of Bone and Joint Surgery, British Volume 77-B (1), pp.159-160. (10.1302/0301-620X.77B1.7822381)
- Singh, G. , Wijesurendra, C. S. and Green, J. T. 1994. Disseminated aspergillosis in the acquired immunodeficiency syndrome. International Journal of STD & AIDS 5 (1), pp.63-66. (10.1177/095646249400500116)
Book sections
- Sugamaran, A. , Hurley, J. and Green, J. 2016. The liver. In: Fillit, H. M. , Rockwood, K. and Young, J. B. eds. Brocklehurst's Textbook of Geriatric Medicine and Gerontology. Elsevier. , pp.596-605.
- Rhodes, J. , Green, J. and Thomas, G. 1998. Nicotine and the gastrointestinal tract. In: Benowitz, N. L. ed. Nicotine Safety and Toxicity. Oxford University Press. , pp.161-166. (10.1093/oso/9780195114966.003.0015)
- Rhodes, J. and Green, J. T. 1998. Alternative concepts for the aetiology and pathogenesis of inflammatory bowel disease. In: Campieri, M. et al., Clinical Challenges in Inflammatory Bowel Diseases: Diagnosis, Prognosis and Treatment: 97 (Falk Symposium, 97). Kluwer Academic Publishers. , pp.25-28.
- Rhodes, J. , Thomas, G. A. and Green, J. T. 1996. Nicotine for the treatment of ulcerative colitis. In: Opitz, K. ed. Nicotine as a Therapeutic Agent. Symposium der Stiftung Immunitat und Umwelt May 15 1996. Immunity and Environment Gustav Fischer. , pp.12-14.
Books
- Shakespeare, R. , Green, J. and Turner, J. 2017. Eureka: Gastrointestinal medicine. Scion Publishing Ltd.
Conferences
- Wildman, A. et al., 2023. Do medical students value continuity of educational supervision?. Presented at: INHWE 3rd International Congress of Health Education and Research & AoME Annual Academic Meeting Cardiff 27-29 June 2023.
Monographs
- Green, J. et al. 2019. JAG accreditation programme. Meeting the quality and safety standards guidance. Project Report.London: Royal College of Physicians.
Ymchwil
Ymgymerais â MD fel Hyfforddai Ôl-raddedig a dyfarnwyd hwn i mi yn 2000 – fy ngoruchwyliwr oedd yr Athro John Rhodes, Ysbyty Athrofaol Cymru, Caerdydd – ei deitl oedd 'Topical nicotine for ulcerative colitis'.
Wedi hynny, rwyf wedi parhau i ymwneud fel clinigydd ac addysgwr meddygol :-
· Prosiectau goruchwyliwr BSc Addysg Feddygol Rhyngweithiol: (2019 – 2023)
o Parhad goruchwylio (2022-2023)
o Achosion hir (2021-2022)
o Adborth gwahanol flynyddoedd clinigol (2020-2021)
o Adborth lleoliad hydredol (2020-2021)
o Digwyddiadau dysgu dan oruchwyliaeth (2019-2020)
o Goruchwyliaeth addysgol (2019-2020)
· Goruchwyliwr Cymrodyr Ymchwil Glinigol sy'n gwneud MD's: (2004 - 2014)
o Sensitifrwydd lactos ac IBD (2014)
o Symptomau abdomenol swyddogaethol a ffactorau seicolegol mewn IBD (2014)
o Effeithiau GI ar ôl radiotherapi pelfis'
· Goruchwylio o leiaf 1 prosiect/blwyddyn academaidd SSC Bl 3 a/neu Bl 4 (2010 -)
- Aelod o'r Bwrdd Cynghori - Journal of the Academy of Medcial Educators (2026 -)
- Golygydd Academaidd, Bwrdd Golygyddol 'PLoS ONE' (2013 – 2018)
· Adolygydd llawysgrif ar gyfer: (1998 - presennol)
o Cylchgrawn Meddygon Myfyrwyr Prydain
o Clefydau Treulio a Gwyddorau
o Adroddiadau Gwyddonol
o BMC Canser
o Arfarniadau Tystiolaeth Technoleg Iechyd Cymru
o Asesiadau Technoleg y Sefydliad Cenedlaethol ar gyfer Ymchwil Iechyd
o BMJ Gastroenteroleg Agored
o Ffarmacoleg a Therapiwteg Bwyd
o World Journal Gastroenterology
o Gastroenteroleg rheng flaen
o Cyfnodolyn Llawfeddygaeth Canser
o Gofal Cefnogol mewn Canser
o Cyfnodolyn Llawfeddygaeth Prydain
o BMJ Gofal Cefnogol a Lliniarol
o Cyfnodolyn Meddygaeth Arbrofol Tohoku
o Sefydliad Cenedlaethol Ymchwil Iechyd Horizon Scanning Central
o Ymgeisydd PhD Ten o vus
o 2014 BSG Abstracts – Datblygiadau gwasanaethau clinigol
o Elusen Henry Smith, DU
· Cyd-ymchwilydd ar yr astudiaeth aml-ganolfan 'EAGLE' yn y DU – cefnogi cleifion ag effeithiau GI ar ôl ymbelydredd pelfis ar gyfer y prostad (2014 -2018)
· Dyfarnwyd £30K gan Tenovus fel prif ymchwilydd ar dreial clinigol 'Developing a simple screening tool to detect chronic gastrointestinal (GI) symptoms after pelvic radio-therapy in cancer survivors' (DYLUNYDD) (2013 -2014) )
Addysgu
Yn fy rolau arwain o fewn yr Ysgol Meddygaeth, rwyf wedi datblygu ac arwain llawer o elfennau o'n cwrs israddedig meddygol. Rwyf hefyd yn addysgu sgiliau endosgopig i ôl-raddedigion, asesu / achredu'r rhai sy'n dymuno dod yn colonosgopyddion sgrinio canser y coluddyn ac rwyf wedi bod yn gyfadran ar gyrsiau hyfforddi cenedlaethol. Mae fy rolau addysgu israddedig presennol yn cynnwys:
· Arweinydd Rhaglen ar gyfer cyrsiau israddedig a addysgir, Ysgol Meddygaeth
· Arweinydd ar gyfer y 2 achos Gastroenteroleg (ym Mlynyddoedd 1 a 2 MBBCh)
· Hwylusydd ar gyfer dysgu tîm sy'n canolbwyntio ar achosion (Blwyddyn 1)
· Rwy'n cyflwyno sesiynau llawn (Blynyddoedd 1 i 3 / myfyrwyr gwadu) a sesiynau grŵp bach (Blynyddoedd 1 i 3)
· Goruchwyliwr Addysgol ar gyfer myfyrwyr MBBCh Blwyddyn 3 yng Nghaerdydd a'r Fro HB
· Tiwtor personol i fyfyrwyr MBBCh
· Datblygu a chyflwyno addysgu Gastroenteroleg (pob blwyddyn)
· Ysgrifennu cwestiynau (MCQs a gorsafoedd ISCE yr ateb gorau sengl
· Gwiriadau allweddol ar ôl profion ar gyfer Profion Cynnydd
· Arholwr ar gyfer ISCEs blwyddyn 2 a blwyddyn 4
· Goruchwylio Cydrannau a Ddewiswyd gan Fyfyrwyr ym Mlynyddoedd 3 a 4 (mae'r meysydd pwnc yn cynnwys Gastroenteroleg ac Addysg Feddygol
Bywgraffiad
Prifysgol (Canolfan Addysg Feddygol, Ysgol Feddygaeth, Prifysgol Caerdydd)
Teitlau Swyddi
· Darllenydd Clinigol (2021 –)
· Uwch Ddarlithydd Clinigol (2009 - 2021)
Rolau arwain
· Cyrsiau Israddedig Arweiniol Rhaglen (2026 –)
· Cyfarwyddwr Cyd-Raglen, MBBCh (2023 – 2026)
· Dirprwy Gyfarwyddwr Rhaglen, MBBCh (2018 – 2023)
· Cyfarwyddwr Blwyddyn 3, MBBCh (2011-2019)
· Trefnydd UG Ysbyty Llandochau / Uwch Ddarlithydd Anrhydeddus (2003–2009)
Clinigol (Bwrdd Iechyd Prifysgol Caerdydd a'r Fro)
Teitlau Swyddi
· Gastroenterolegydd Ymgynghorol (2001 -)
· Swyddi dan hyfforddiant mewn Gastroenteroleg a Meddygaeth Gyffredinol - De Cymru a Birmingham (1991 - 2001)
· Cymrawd Ymchwil mewn Gastroenteroleg yn Prifysgol Prifysgol ( 1995 - 1998)
Rolau Arweinyddiaeth
· Sgrinio Canser y Coluddyn Cymeradwy Sgrinio Coluddyn Colonosgopydd Cymru (BSW) (2008 –)
· Colonosgopydd Sgrinio Canser y Coluddyn Achredwr (BSW) (2020 –)
· Panel Cynghori Meddygol – Cymdeithas Clefyd Ymbelydredd y Pelfig (2022 –)
· Arweinydd clinigol y Rhaglen Endosgopeg Genedlaethol, Cymru (2019 – 2025)
· Llywydd Cymdeithas Gastroenteroleg ac Endosocpy Cymru (WAGE) (2022 - 2024)
· Is-lywydd WAGE (2020 - 2022)
· Arweinydd endosgopi / cadeirydd EUG Bwrdd Iechyd Prifysgol Caerdydd a'r Fro (2007 – 2021)
- Cadeirydd Grŵp QA Gwasanaethau Endosgopi (ESQAG) Grŵp Cynghori ar y Cyd ar Endosgopi Gastroberfeddol (JAG), Meddygon Coleg Oyal, Llundain (2016 – 2019)
- Aseswr arweiniol ymweliadau adolygu cymheiriaid achrediad JAG (2013 – 2019)
- Cyfarwyddwr Clinigol Gastroenteroleg, C&V UHB (2017 – 2018)
- Dirprwy Gyfarwyddwr Clinigol Gastroenteroleg, C&V UHB (2013 – 2017)
- Arweinydd Clinigol ar gyfer Endosgopi yng Nghymru (Asiantaeth Arloesi Arweinyddiaeth Genedlaethol ar gyfer Gofal Iechyd) (2011 – 2016)
· Asesiad Ansawdd JAG Cynrychiolydd Cymru o Weithgor Unedau (QAUWG) (2009 – 2016)
· RCP Llundain, Cynghorydd Arbenigedd Rhanbarthol ar gyfer Gastroenteroleg (2012-2014)
· Pwyllgor Safonau a Gwasanaethau Clinigol Cymdeithas Gastroenteroleg Prydain Cynrychiolydd Rhanbarthol Cymru (2012 - 2014)
· Pwyllgor Datganoli BSG - Cynrychiolydd Cymru (2012 – 2014)
· Pwyllgor cyflog. Pwyllgor trefnu ar gyfer cyfarfod ar y cyd BSW/WAGE yng Nghaerdydd 2014 (2010 - 2014)
- Adolygydd Cymheiriaid ar ymweliadau'r Grŵp Cynghori ar y Cyd ag Unedau Endosgopi y DU a ROI / Cyfadran ar Ddiwrnodau Hyfforddi (2010 – 2013)
· Arweinydd Clinigol De Ddwyrain Cymru ar gyfer Endosgopeg yng Nghymru (NLIAH) (2007 – 2010)
· Ysgrifennydd Uwch Bwyllgor Staff Ysbyty Llandochau (2003 - 2009)
· Cadeirydd Cenedlaethol 'Hyfforddeion mewn Gastroenteroleg' (2000 - 2001)
· Cynrychiolydd hyfforddeion ar bwyllgor a Chyngor Hyfforddiant BSG (2000 - 2001)
· Aelod o'r Pwyllgor 'Hyfforddeion mewn Gastroenteroleg' (1997- 2001)
Addysg
· Coleg Meddygaeth Prifysgol Cymru, Caerdydd (1986 - 1991)
· Ysgol Uwchradd Sirol Aberteifi (1979 - 1986)
Anrhydeddau a dyfarniadau
· Academi Cymrodoriaeth Addysgwyr Meddygol (FAcadMEd) ( 2014)
· Tystysgrif Ôl-raddedig Addysg Feddygol (Prifysgol Caerdydd) (2010)
· Cymrodoriaeth Meddygon Coleg Brenhinol Llundain (FRCP) (2005)
· CCST mewn Gastroenteroleg a Meddygaeth Fewnol Gyffredinol (2000)
· MD (Cymru) - 'Topical nicotine for ulcerative colitis' (2000)
· Aelodaeth Meddygon Coleg Brenhinol Llundain (MRCP) Mawrth (1994)
- MB Bch (Cymru) – Anrhydeddau mewn Llawfeddygaeth, Anatomeg a Biocemeg aGwobr Willie Seager am Lawfeddygaeth. (1991)
· Cefais fy enwebu ar gyfer Gwobr Dathlu Rhagoriaeth Prifysgol Caerdydd 2019, yn y categori 'Gwelliant Eithriadol o Brofiad Dysgu Myfyrwyr'
· Enillais wobrau Rhagoriaeth Addysgu (Israddedig) a thîm y flwyddyn. Ysgol Feddygaeth Caerdydd 2012 a chyrhaeddodd restr fer 'Athro Clinigol y Flwyddyn' yng Ngwobrau Dysgu BMA Cymru a BMJ 2013.
Aelodaethau proffesiynol
- Cyngor Meddygol Cyffredinol
- Meddyg y Coleg Brenhinol (Llundain) - Cymrawd
- Cymdeithas Feddygol Prydain
- Cymdeithas Prydain Gastroenteroleg
- Cymdeithas Diogelu Meddygol
- Cymdeithas Gastroenteroleg ac Endosgopi Cymru
- Academi Addysgwyr Meddygol - Cymrawd
Safleoedd academaidd blaenorol
Gweler fy mywgraffiad os gwelwch yn dda
Pwyllgorau ac adolygu
Rwy'n cadeirio ac yn mynychu llawer o baneli prifysgol o fewn fy rôl – mae'r rhain yn cynnwys Byrddau Arholi, Bwrdd Astudiaethau'r Brifysgol, Gweithrediaeth y Ganolfan Addysg Feddygol, Panel Myfyrwyr Staff, Gweithrediaeth MBBCh, Grŵp Cyflawni Rhaglenni, paneli thema Asesu, grwpiau AaGIC, gweithgor Addysgeg y Dyfodol Cwricwlwm 2023 ac ati. Rwyf hefyd wedi ymgymryd â dyletswyddau archwilio allanol yn cefnogi sefydliadau eraill.
Contact Details
[email protected]
+44 29225 11590
Adeilad Cochrane, Llawr 2il, Parc y Mynydd Bychan, Caerdydd, CF14 4YU
+44 29225 11590
Adeilad Cochrane, Llawr 2il, Parc y Mynydd Bychan, Caerdydd, CF14 4YU
Themâu ymchwil
Arbenigeddau
- Addysg Feddygol
- Gastroenteroleg
- Endosgopi